Weiren Huang

Publication Activity (10 Years)

Years Active: 2024-2024
Publications (10 Years): 5

Top Topics

High Efficiency

Gene Expression

Small Cell Lung Cancer

Top Venues

This page only lists publications with an associated author ORCID identifier.

Publications

Xianteng Wang, Ting Guo, Liman Niu, Binbin Zheng, Wei Huang, Haibo Xu, Weiren Huang
Engineered targeting OIP5 sensitizes bladder cancer to chemotherapy resistance via TRIP12-PPP1CB-YBX1 axis. Oncogene (2024)
Xianteng Wang, Xingkai Li, Liman Niu, Fang Lv, Ting Guo, Yushun Gao, Yu-Liang Ran, Weiren Huang, Bing Wang
FAK-LINC01089 negative regulatory loop controls chemoresistance and progression of small cell lung cancer. Oncogene 43 (22) (2024)
Xianteng Wang, Xingkai Li, Liman Niu, Fang Lv, Ting Guo, Yushun Gao, Yu-Liang Ran, Weiren Huang, Bing Wang
FAK-LINC01089 negative regulatory loop controls chemoresistance and progression of small cell lung cancer. Oncogene 43 (22) (2024)
Xianteng Wang, Ting Guo, Liman Niu, Binbin Zheng, Wei Huang, Haibo Xu, Weiren Huang
Engineered targeting OIP5 sensitizes bladder cancer to chemotherapy resistance via TRIP12-PPP1CB-YBX1 axis. Oncogene (2024)
Xianteng Wang, Xingkai Li, Liman Niu, Fang Lv, Ting Guo, Yushun Gao, Yu-Liang Ran, Weiren Huang, Bing Wang
FAK-LINC01089 negative regulatory loop controls chemoresistance and progression of small cell lung cancer. Oncogene (2024)